PaizaBio Introduces Aseptic Services for China Market

Published on: 

Contract manufacturer PiazaBio announces services for Western Pharma companies seeking to enter the China market.

PaizaBio, a contract manufacturer and marketing agent based in Albuquerque, NM, USA, has announced sterile injectable services for Western pharmaceutical companies seeking entry into China’s market.

PaizaBio reports in a company announcement that it has implemented processes and services to ensure quality, competitiveness, and transparency in China, including a training program for a qualified aseptic workforce; a digital and video production monitoring system; and lyophilization services.

The company’s manufacturing presence in China includes a 40,000-square-meter compound, encompassing a 25,000-square-meter production facility and 10,000-square-meter warehouse. Production equipment includes nine automated filling lines for vials, cartridges and syringes; 10 capping lines; a packaging facility with automated and manual options; four formulation tanks with a capacity of 3,000 liters; and laboratory facilities for testing, validation, analysis, and development. Additionally, the company offers clients expertise in Chinese regulatory compliance.


Soource: PaizaBio